ERNA

NASD Ernexa Therapeutics Inc.
Oct 21, 2026 · 6:39 PM ET LAST TRADE Market Closed

$2.32 ↑ +0.21 (+10.04%) Trading Up from the previous close of $2.11, and at the day’s high of $2.26

YTD change
-92.26%
vs 20-day SMA
-13.51%
vs 200-day SMA
-72.83%

Price ranges

Previous day
$1.89 $2.26
open $1.90 close $2.24
+$0.34 (+17.89%)
Today
$2.08 $2.26
open $2.25 now $2.32
+$0.07 (+3.19%)
Past week
$1.84 $2.26
from $2.21 now $2.32
+$0.11 (+5.06%)
Past month
$1.84 $3.85
from $3.80 now $2.32
-$1.48 (-38.90%)
This year
$0.13 $30.00
from $30.00 now $2.32
-$27.68 (-92.26%)

Price & Performance

+2.05 (+1074.62%) / 6M

$-0.9310$4.28$9.50$14.71Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 99.9% away from all-time highs of $2,681.25
  • ERNA is down 92% since the beginning of the year
  • ERNA is down 92% over the past 12 months
  • ERNA is down 39% over the past 1 month
  • 1% of all ERNA investors are betting against ERNA

ERNA reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +85.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-3.3
Earnings momentum +14.1% Quarterly EPS growth
Quarterly change +14.1%

Valuation

P/E ratio N/A
Enterprise value $-2028080.0
Beta 3.69

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$5.0M
Debt$349.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $3.8M

Ernexa Therapeutics, Inc. engages in the research and development of cellular therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. Its pipeline includes ERNA-101 (Ovarian Cancer) and ERNA-201 (Rheumatoid Arthritis). The company was founded in 1984 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,283.66 +3.49%
JNJ Johnson & Johnson $259.36 +2.19%
ABBV AbbVie, Inc. $289.08 +2.26%
MRK Merck & Co., Inc. $148.30 +3.25%
RHHVF Roche Holding Ltd $475.00 +3.69%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.